Health · 1 sources covering this

STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more

The Trump administration is advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and PTSD

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more
The Trump administration is advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and PTSD
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/c294967f92b94c9ec90745769d0501dd4d402a2d"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about U.S.-funded psychedelic trials, an AstraZeneca R&#038;D center, and more"></iframe>

STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more

How 1 sources are covering this

STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more

More from Health

STAT+: AstraZeneca opens new Boston site

STAT+: Are stem cell treatments about to have their day?

What are hospital longevity programs, and what can they tell you about your health?

STAT+: FDA spells out 2027 AI guidance plans

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Pharmalittle: We&#8217;re reading about U.S.-funded psychedelic trials, an AstraZeneca R&#038;D center, and more

More from Health

STAT+: AstraZeneca opens new Boston site

STAT+: Are stem cell treatments about to have their day?

What are hospital longevity programs, and what can they tell you about your health?

STAT+: FDA spells out 2027 AI guidance plans

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more